Stock Updates

Is this Large Market Cap Stock target price reasonable for Boston Scientific Corporation (NYSE:BSX)?

The company in question is, Boston Scientific Corporation (NYSE:BSX) currently with a stock price of 23.93 (-0.87% today). The market cap for Boston Scientific Corporation is 32795.4, and is in the sector Healthcare, and Medical Appliances & Equipment industry. The target price for Boston Scientific Corporation is 27.26. Currently Boston Scientific Corporation is trading with a P/E of *TBA, and a forward P/E of 19.24. Average volume for Boston Scientific Corporation is 10681.41 and so far today it is 2035129.

Performance in the last year for Boston Scientific Corporation has been 38.58%. For EPS growth, Boston Scientific Corporation has seen a growth of -98.30%, and is looking to grow in the next year to 14.30%. More long term stats show that EPS growth has been 24.00% over the last five years and could be 13.07% for the next five years. Boston Scientific Corporation has seen sales growth quarter over quarter at 15.40%, with EPS growth quarter over quarter at -303.60%. The 20-day simple moving average is 2.65%, with the 200-day simple moving average coming to 20.77%.

Since the IPO date for Boston Scientific Corporation on the 5/19/1992, Boston Scientific Corporation has seen performance year to date to be 30.91%. With Boston Scientific Corporation trading at 23.93, the dividend yield is *TBA, and the EPS is -0.26.

So could Boston Scientific Corporation, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 4.12 and the P/B is at 5.27. The P/cash is 74.88, with P/free cash flow at 45.74.

Boston Scientific Corporation ability to deal with debt shows that the current ratio is 1, and the quick ratio is 0.7. This is with long term debt/equity at 0.83, and total debt/equity at 0.87.

In terms of margins, Boston Scientific Corporation has a gross margin of 71.10%, an operating margin of -7.70% and a profit margin of -4.30%.Payout ratio for Boston Scientific Corporation is *TBA. Return on assets come to -1.90% with return on investment coming to 0.70%.

Insider ownership for Boston Scientific Corporation, is at 0.50% and institutional ownership comes to 94.80%. Outstanding shares are at 1358.55. While shares float is 1343.72. The float short is currently 1.73%, and short ratio is 2.18.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment